Moderna Coronavirus Vaccine Approved in Europe

Less than a month after winning emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its coronavirus vaccine, Moderna (NASDAQ:MRNA) has scored another major regulatory nod.

On Wednesday, the company announced that the European Commission -- the executive arm of the 27-country European Union (EU) -- granted conditional marketing authorization (CMA) for the company's mRNA-1273.